TIP regimen
WikiDoc Resources for TIP regimen |
Articles |
---|
Most recent articles on TIP regimen Most cited articles on TIP regimen |
Media |
Powerpoint slides on TIP regimen |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on TIP regimen at Clinical Trials.gov Clinical Trials on TIP regimen at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on TIP regimen
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on TIP regimen Discussion groups on TIP regimen Patient Handouts on TIP regimen Directions to Hospitals Treating TIP regimen Risk calculators and risk factors for TIP regimen
|
Healthcare Provider Resources |
Causes & Risk Factors for TIP regimen |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:Taxol-Ifosfamide-Platinol Regimen; TIP Regimen
Overview
TIP regimen refers to a regimen consisting of paclitaxel, ifosfamide, mesna and cisplatin used for the treatment of advanced-stage testicular cancer; also used for the treatment of unresectable and recurrent squamous cell head and neck cancer.[1]
Regimen
TTaxol (paclitaxel)
IIfosfamide
PPlatinol (cisplatin)
Indications
References
- ↑ 1.0 1.1 Pohl G, Krajnik G, Malayeri R, Müller RM, Klepetko W, Eckersberger F; et al. (2006). "Induction chemotherapy with the TIP regimen (paclitaxel/ifosfamide/cisplatin) in stage III non-small cell lung cancer". Lung Cancer. 54 (1): 63–7. doi:10.1016/j.lungcan.2006.05.027. PMID 16926060.
- ↑ "NCI Thesaurus".